ID   MGMT_HUMAN              Reviewed;         207 AA.
AC   P16455; Q5VY78;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   01-AUG-1990, sequence version 1.
DT   15-MAR-2017, entry version 178.
DE   RecName: Full=Methylated-DNA--protein-cysteine methyltransferase;
DE            EC=2.1.1.63;
DE   AltName: Full=6-O-methylguanine-DNA methyltransferase;
DE            Short=MGMT;
DE   AltName: Full=O-6-methylguanine-DNA-alkyltransferase;
GN   Name=MGMT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 1-8.
RX   PubMed=2405387; DOI=10.1073/pnas.87.2.686;
RA   Tano K., Shiota S., Collier J., Foote R.S., Mitra S.;
RT   "Isolation and structural characterization of a cDNA clone encoding
RT   the human DNA repair protein for O6-alkylguanine.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:686-690(1990).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2188979;
RA   Rydberg B., Spurr N., Karran P.;
RT   "cDNA cloning and chromosomal assignment of the human O6-
RT   methylguanine-DNA methyltransferase. cDNA expression in Escherichia
RT   coli and gene expression in human cells.";
RL   J. Biol. Chem. 265:9563-9569(1990).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2394694;
RA   Koike G., Maki H., Takeya H., Hayakawa H., Sekiguchi M.;
RT   "Purification, structure, and biochemical properties of human O6-
RT   methylguanine-DNA methyltransferase.";
RL   J. Biol. Chem. 265:14754-14762(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=2359121; DOI=10.1016/S0022-2836(05)80260-8;
RA   Hayakawa H., Koike G., Sekiguchi M.;
RT   "Expression and cloning of complementary DNA for a human enzyme that
RT   repairs O6-methylguanine in DNA.";
RL   J. Mol. Biol. 213:739-747(1990).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Cahill P., Camire D.,
RA   Carter N.P., Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S.,
RA   Corby N., Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L.,
RA   Frankish A., Frankland J.A., Garner P., Garnett J., Gribble S.,
RA   Griffiths C., Grocock R., Gustafson E., Hammond S., Harley J.L.,
RA   Hart E., Heath P.D., Ho T.P., Hopkins B., Horne J., Howden P.J.,
RA   Huckle E., Hynds C., Johnson C., Johnson D., Kana A., Kay M.,
RA   Kimberley A.M., Kershaw J.K., Kokkinaki M., Laird G.K., Lawlor S.,
RA   Lee H.M., Leongamornlert D.A., Laird G., Lloyd C., Lloyd D.M.,
RA   Loveland J., Lovell J., McLaren S., McLay K.E., McMurray A.,
RA   Mashreghi-Mohammadi M., Matthews L., Milne S., Nickerson T.,
RA   Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V., Peck A.I.,
RA   Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A., Ross M.T.,
RA   Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W.,
RA   Tracey A., Tromans A., Tsolas J., Wall M., Walsh J., Wang H.,
RA   Weinstock K., West A.P., Willey D.L., Whitehead S.L., Wilming L.,
RA   Wray P.W., Young L., Chen Y., Lovering R.C., Moschonas N.K.,
RA   Siebert R., Fechtel K., Bentley D., Durbin R.M., Hubbard T.,
RA   Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PARTIAL PROTEIN SEQUENCE, AND ALKYL GROUP ACCEPTOR.
RX   PubMed=1985934;
RA   von Wronski M.A., Shiota S., Tano K., Mitra S., Bigner D.D.,
RA   Brent T.P.;
RT   "Structural and immunological comparison of indigenous human O6-
RT   methylguanine-DNA methyltransferase with that encoded by a cloned
RT   cDNA.";
RL   J. Biol. Chem. 266:1064-1070(1991).
RN   [10]
RP   CHARACTERIZATION.
RX   PubMed=8202360; DOI=10.1093/nar/22.9.1613;
RA   Liem L.-K., Lim A., Li B.F.L.;
RT   "Specificities of human, rat and E. coli O6-methylguanine-DNA
RT   methyltransferases towards the repair of O6-methyl and O6-ethylguanine
RT   in DNA.";
RL   Nucleic Acids Res. 22:1613-1619(1994).
RN   [11]
RP   MUTAGENESIS OF PRO-138; PRO-140 AND GLY-156.
RX   PubMed=7954470;
RA   Crone T.M., Goodtzova K., Edara S., Pegg A.E.;
RT   "Mutations in human O6-alkylguanine-DNA alkyltransferase imparting
RT   resistance to O6-benzylguanine.";
RL   Cancer Res. 54:6221-6227(1994).
RN   [12]
RP   MUTAGENESIS OF TYR-114; ARG-128 AND CYS-145.
RX   PubMed=7766621; DOI=10.1021/bi00021a024;
RA   Kanugula S., Goodtzova K., Edara S., Pegg A.E.;
RT   "Alteration of arginine-128 to alanine abolishes the ability of human
RT   O6-alkylguanine-DNA alkyltransferase to repair methylated DNA but has
RT   no effect on its reaction with O6-benzylguanine.";
RL   Biochemistry 34:7113-7119(1995).
RN   [13]
RP   MUTAGENESIS OF TYR-158.
RX   PubMed=7614699; DOI=10.1093/carcin/16.7.1637;
RA   Edara S., Goodtzova K., Pegg A.E.;
RT   "The role of tyrosine-158 in O6-alkylguanine-DNA alkyltransferase
RT   activity.";
RL   Carcinogenesis 16:1637-1642(1995).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-14 AND SER-201, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-201, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) IN COMPLEX WITH DNA AND ZINC
RP   IONS, AND MUTAGENESIS OF ARG-128 AND CYS-145.
RX   PubMed=10747039; DOI=10.1093/emboj/19.7.1719;
RA   Daniels D.S., Mol C.D., Arvai A.S., Kanugula S., Pegg A.E.,
RA   Tainer J.A.;
RT   "Active and alkylated human AGT structures: a novel zinc site,
RT   inhibitor and extrahelical base binding.";
RL   EMBO J. 19:1719-1730(2000).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 1-176.
RX   PubMed=10606635; DOI=10.1093/nar/28.2.393;
RA   Wibley J.E., Pegg A.E., Moody P.C.;
RT   "Crystal structure of the human O(6)-alkylguanine-DNA
RT   alkyltransferase.";
RL   Nucleic Acids Res. 28:393-401(2000).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS) OF 1-179 IN COMPLEX WITH DNA AND
RP   ZINC IONS.
RX   PubMed=15964013; DOI=10.1016/j.jmb.2005.05.028;
RA   Duguid E.M., Rice P.A., He C.;
RT   "The structure of the human AGT protein bound to DNA and its
RT   implications for damage detection.";
RL   J. Mol. Biol. 350:657-666(2005).
CC   -!- FUNCTION: Involved in the cellular defense against the biological
CC       effects of O6-methylguanine (O6-MeG) in DNA. Repairs alkylated
CC       guanine in DNA by stoichiometrically transferring the alkyl group
CC       at the O-6 position to a cysteine residue in the enzyme. This is a
CC       suicide reaction: the enzyme is irreversibly inactivated.
CC   -!- CATALYTIC ACTIVITY: DNA (containing 6-O-methylguanine) + protein
CC       L-cysteine = DNA (without 6-O-methylguanine) + protein S-methyl-L-
CC       cysteine. {ECO:0000255|PROSITE-ProRule:PRU10017}.
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105;
CC       Note=Binds 1 zinc ion.;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- MISCELLANEOUS: This enzyme catalyzes only one turnover and
CC       therefore is not strictly catalytic. According to one definition,
CC       an enzyme is a biocatalyst that acts repeatedly and over many
CC       reaction cycles.
CC   -!- SIMILARITY: Belongs to the MGMT family. {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; X54228; CAA38137.1; -; mRNA.
DR   EMBL; M29971; AAA59596.1; -; mRNA.
DR   EMBL; M31767; AAA52317.1; -; mRNA.
DR   EMBL; M60761; AAA59594.1; -; mRNA.
DR   EMBL; BT006714; AAP35360.1; -; mRNA.
DR   EMBL; AL157832; CAH70060.1; -; Genomic_DNA.
DR   EMBL; AL355531; CAH70060.1; JOINED; Genomic_DNA.
DR   EMBL; AL355531; CAH72190.1; -; Genomic_DNA.
DR   EMBL; AL157832; CAH72190.1; JOINED; Genomic_DNA.
DR   EMBL; CH471066; EAW49166.1; -; Genomic_DNA.
DR   EMBL; BC000824; AAH00824.1; -; mRNA.
DR   PIR; A34889; XUHUMC.
DR   RefSeq; XP_005252739.1; XM_005252682.2.
DR   UniGene; Hs.501522; -.
DR   PDB; 1EH6; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH7; X-ray; 2.00 A; A=1-207.
DR   PDB; 1EH8; X-ray; 2.50 A; A=1-207.
DR   PDB; 1QNT; X-ray; 1.90 A; A=1-176.
DR   PDB; 1T38; X-ray; 3.20 A; A=1-176.
DR   PDB; 1T39; X-ray; 3.30 A; A/B=1-176.
DR   PDB; 1YFH; X-ray; 3.01 A; A/B/C=1-179.
DR   PDBsum; 1EH6; -.
DR   PDBsum; 1EH7; -.
DR   PDBsum; 1EH8; -.
DR   PDBsum; 1QNT; -.
DR   PDBsum; 1T38; -.
DR   PDBsum; 1T39; -.
DR   PDBsum; 1YFH; -.
DR   ProteinModelPortal; P16455; -.
DR   SMR; P16455; -.
DR   BioGrid; 110411; 74.
DR   IntAct; P16455; 1.
DR   MINT; MINT-5002466; -.
DR   STRING; 9606.ENSP00000302111; -.
DR   BindingDB; P16455; -.
DR   ChEMBL; CHEMBL2864; -.
DR   DrugBank; DB04531; Benzylcysteine.
DR   DrugBank; DB00151; L-Cysteine.
DR   DrugBank; DB02216; S-Methylcysteine.
DR   iPTMnet; P16455; -.
DR   PhosphoSitePlus; P16455; -.
DR   DMDM; 127069; -.
DR   EPD; P16455; -.
DR   MaxQB; P16455; -.
DR   PaxDb; P16455; -.
DR   PeptideAtlas; P16455; -.
DR   PRIDE; P16455; -.
DR   Ensembl; ENST00000306010; ENSP00000302111; ENSG00000170430.
DR   GeneID; 4255; -.
DR   UCSC; uc001lkh.3; human.
DR   CTD; 4255; -.
DR   DisGeNET; 4255; -.
DR   GeneCards; MGMT; -.
DR   H-InvDB; HIX0009309; -.
DR   HGNC; HGNC:7059; MGMT.
DR   HPA; CAB002786; -.
DR   HPA; HPA032135; -.
DR   HPA; HPA032136; -.
DR   MalaCards; MGMT; -.
DR   MIM; 156569; gene.
DR   neXtProt; NX_P16455; -.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   eggNOG; KOG4062; Eukaryota.
DR   eggNOG; COG0350; LUCA.
DR   HOGENOM; HOG000244137; -.
DR   HOVERGEN; HBG001146; -.
DR   InParanoid; P16455; -.
DR   OrthoDB; EOG091G11SR; -.
DR   PhylomeDB; P16455; -.
DR   TreeFam; TF314064; -.
DR   BRENDA; 2.1.1.63; 2681.
DR   Reactome; R-HSA-5657655; MGMT-mediated DNA damage reversal.
DR   ChiTaRS; MGMT; human.
DR   EvolutionaryTrace; P16455; -.
DR   GeneWiki; O-6-methylguanine-DNA_methyltransferase; -.
DR   GenomeRNAi; 4255; -.
DR   PRO; PR:P16455; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000170430; -.
DR   CleanEx; HS_MGMT; -.
DR   ExpressionAtlas; P16455; baseline and differential.
DR   Genevisible; P16455; HS.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0005509; F:calcium ion binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0009008; F:DNA-methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0003908; F:methylated-DNA-[protein]-cysteine S-methyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0008168; F:methyltransferase activity; TAS:ProtInc.
DR   GO; GO:0071479; P:cellular response to ionizing radiation; IEA:Ensembl.
DR   GO; GO:0071407; P:cellular response to organic cyclic compound; IEA:Ensembl.
DR   GO; GO:0034599; P:cellular response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0006307; P:DNA dealkylation involved in DNA repair; TAS:Reactome.
DR   GO; GO:0006266; P:DNA ligation; TAS:ProtInc.
DR   GO; GO:0060644; P:mammary gland epithelial cell differentiation; IEA:Ensembl.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; IDA:BHF-UCL.
DR   GO; GO:2000781; P:positive regulation of double-strand break repair; IDA:BHF-UCL.
DR   GO; GO:0043281; P:regulation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0042493; P:response to drug; IEA:Ensembl.
DR   GO; GO:0045471; P:response to ethanol; IEA:Ensembl.
DR   GO; GO:0051593; P:response to folic acid; IEA:Ensembl.
DR   GO; GO:0009636; P:response to toxic substance; IEA:Ensembl.
DR   CDD; cd06445; ATase; 1.
DR   Gene3D; 1.10.10.10; -; 1.
DR   InterPro; IPR001497; MethylDNA_cys_MeTrfase_AS.
DR   InterPro; IPR014048; MethylDNA_cys_MeTrfase_DNA-bd.
DR   InterPro; IPR008332; MethylG_MeTrfase_N.
DR   InterPro; IPR011991; WHTH_DNA-bd_dom.
DR   Pfam; PF01035; DNA_binding_1; 1.
DR   Pfam; PF02870; Methyltransf_1N; 1.
DR   SUPFAM; SSF46767; SSF46767; 1.
DR   SUPFAM; SSF53155; SSF53155; 1.
DR   TIGRFAMs; TIGR00589; ogt; 1.
DR   PROSITE; PS00374; MGMT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Complete proteome; Direct protein sequencing;
KW   DNA damage; DNA repair; DNA-binding; Metal-binding; Methyltransferase;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transferase; Zinc.
FT   CHAIN         1    207       Methylated-DNA--protein-cysteine
FT                                methyltransferase.
FT                                /FTId=PRO_0000139359.
FT   ACT_SITE    145    145       Nucleophile; methyl group acceptor.
FT   METAL         5      5       Zinc.
FT   METAL        24     24       Zinc.
FT   METAL        29     29       Zinc.
FT   METAL        85     85       Zinc.
FT   BINDING      95     95       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     114    114       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     115    115       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     123    123       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     128    128       DNA. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   BINDING     151    151       DNA; via amide nitrogen.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:15964013}.
FT   MOD_RES      14     14       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     201    201       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   VARIANT      30     30       E -> K (in dbSNP:rs2020893).
FT                                /FTId=VAR_014750.
FT   VARIANT      53     53       L -> F (in dbSNP:rs12917).
FT                                /FTId=VAR_056129.
FT   VARIANT      58     58       P -> S (in dbSNP:rs2308322).
FT                                /FTId=VAR_029112.
FT   VARIANT      65     65       W -> C (in dbSNP:rs2282164).
FT                                /FTId=VAR_020354.
FT   VARIANT      84     84       L -> F (in dbSNP:rs12917).
FT                                /FTId=VAR_014751.
FT   VARIANT     112    112       I -> V (in dbSNP:rs2308321).
FT                                /FTId=VAR_056130.
FT   VARIANT     143    143       I -> V (in dbSNP:rs2308321).
FT                                /FTId=VAR_014752.
FT   VARIANT     160    160       G -> R (in dbSNP:rs2308318).
FT                                /FTId=VAR_014753.
FT   VARIANT     166    166       E -> D (in dbSNP:rs2308320).
FT                                /FTId=VAR_014754.
FT   VARIANT     178    178       K -> R (in dbSNP:rs2308327).
FT                                /FTId=VAR_014755.
FT   MUTAGEN     114    114       Y->A: Decreases activity towards
FT                                methylated DNA over 1000-fold. Slightly
FT                                reduced reactivity with O6-benzylguanine.
FT                                {ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     114    114       Y->E: Loss of DNA repair activity.
FT                                Slightly reduced reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->A,D: Decreases activity towards
FT                                methylated DNA over 1000-fold. No effect
FT                                on reactivity with O6-benzylguanine.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->G: Loss of DNA repair activity.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     128    128       R->K,L: Slightly reduced DNA repair
FT                                activity. {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     138    138       P->K: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     140    140       P->A: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     145    145       C->A: Loss of DNA repair activity.
FT                                {ECO:0000269|PubMed:10747039,
FT                                ECO:0000269|PubMed:7766621}.
FT   MUTAGEN     156    156       G->A: Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7954470}.
FT   MUTAGEN     158    158       Y->A: Reduced DNA repair activity.
FT                                Decreased reactivity with O6-
FT                                benzylguanine.
FT                                {ECO:0000269|PubMed:7614699}.
FT   MUTAGEN     158    158       Y->F: Slightly reduced DNA repair
FT                                activity. {ECO:0000269|PubMed:7614699}.
FT   CONFLICT    127    127       A -> T (in Ref. 2; AAA52317).
FT                                {ECO:0000305}.
FT   STRAND        8     12       {ECO:0000244|PDB:1QNT}.
FT   STRAND       19     24       {ECO:0000244|PDB:1QNT}.
FT   STRAND       27     33       {ECO:0000244|PDB:1QNT}.
FT   STRAND       50     52       {ECO:0000244|PDB:1EH6}.
FT   HELIX        57     71       {ECO:0000244|PDB:1QNT}.
FT   HELIX        73     78       {ECO:0000244|PDB:1QNT}.
FT   HELIX        87     90       {ECO:0000244|PDB:1QNT}.
FT   HELIX        94    105       {ECO:0000244|PDB:1QNT}.
FT   HELIX       114    120       {ECO:0000244|PDB:1QNT}.
FT   TURN        124    126       {ECO:0000244|PDB:1T38}.
FT   HELIX       127    134       {ECO:0000244|PDB:1QNT}.
FT   STRAND      138    140       {ECO:0000244|PDB:1QNT}.
FT   HELIX       145    147       {ECO:0000244|PDB:1QNT}.
FT   HELIX       162    171       {ECO:0000244|PDB:1QNT}.
SQ   SEQUENCE   207 AA;  21646 MW;  76BBF19DFC4512D6 CRC64;
     MDKDCEMKRT TLDSPLGKLE LSGCEQGLHE IKLLGKGTSA ADAVEVPAPA AVLGGPEPLM
     QCTAWLNAYF HQPEAIEEFP VPALHHPVFQ QESFTRQVLW KLLKVVKFGE VISYQQLAAL
     AGNPKAARAV GGAMRGNPVP ILIPCHRVVC SSGAVGNYSG GLAVKEWLLA HEGHRLGKPG
     LGGSSGLAGA WLKGAGATSG SPPAGRN
//
